Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology News Journal.
Press releases published on April 2, 2025

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it will demonstrate its multimodal vision transformer (ViT) at ISC West 2025 in Las Vegas, April 2-4. Deployed on an …

Building on Past Success, Incident IQ Names Ryan Zeek as Chief Financial Officer
ATLANTA, April 02, 2025 (GLOBE NEWSWIRE) -- Incident IQ, the leading workflow management platform built specifically to streamline K-12 school districts, has announced the appointment of Ryan Zeek as Chief Financial Officer. Ryan steps into the role after …

SchoolAI Secures $25 Million to Help Teachers and Schools Reach Every Student
LEHI, Utah, April 02, 2025 (GLOBE NEWSWIRE) -- SchoolAI, a leading AI platform for teaching and learning, today announced it has closed $25 million in Series A funding to tackle education’s fundamental challenge: helping teachers provide personalized …

The NHL and Rogers Announce Monumental 12-Year National Media Rights Deal
Renews highly coveted and valuable hockey rights long term Will deliver more national games and fewer blackouts to hockey fans Rogers is proud to remain the home of NHL hockey TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- Rogers Communications and the …

La LNH et Rogers annoncent un accord monumental de 12 ans pour les droits de diffusion nationaux
Ces droits très convoités et d’une grande valeur sont renouvelés à long terme L’accord promet aux fans de hockey plus de matchs nationaux et moins de rencontres frappées par des interdictions de diffusion Rogers est fière de demeurer la destination …

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment
Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment First subjects dosed in double-blind, placebo-controlled trial assessing AT-7687’s safety, tolerability, …

Le secteur de la construction au Manitoba devrait connaître une croissance saine de l’activité résidentielle et non résidentielle d’ici 2034
OTTAWA, Ontario, 02 avr. 2025 (GLOBE NEWSWIRE) -- L’activité de construction a enregistré une légère hausse au Manitoba en 2024, la croissance du secteur non résidentiel de la province ayant contrebalancé un léger ralentissement du secteur résidentiel. Au …

Manitoba’s construction sector to see healthy growth in residential and non-residential activity to 2034
OTTAWA, Ontario, April 02, 2025 (GLOBE NEWSWIRE) -- Construction activity in Manitoba saw a slight gain in 2024, as growth in the province’s non-residential sector outweighed a slight contraction in the residential sector. The former has been underpinned …

Employee Trust Fuels Financial Success at the 100 Best Companies to Work For in 2025
Oakland, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Can employee trust be measured in dollars and cents? The 2025 Fortune 100 Best Companies to Work For® have proven that the answer is a resounding yes. On average, the 100 Best Companies earn 8.5 times …

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of …

Tilray Shifts Cultivation of its Flagship Canadian Cannabis Brand and Strain, Good Supply Jean Guy, to Masson-Angers Facility in Québec
MASSON-ANGERS, Quebec, April 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc., company (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, and a leader …

Tilray Transfère la Culture de Sa Marque et de Sa Variété Canadienne Emblématique, Good Supply Jean Guy, à son Installation de Masson-Angers au Québec
MASSON-ANGERS, Québec, 02 avr. 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (« Tilray ») (Nasdaq : TLRY ; TSX : TLRY), un leader mondial des biens de consommation, de l’industrie du cannabis, des boissons et du bien-être, ainsi qu'un acteur clé sur le …

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the appointment of Teresa Bitetti, …

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
NEWTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer …

Lantronix Named to CRN 2025 Internet of Things 50 List
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced it has been recognized on the 2025 Internet of Things (IoT) 50 …

Gainsight Acquires Skilljar, Enabling Learning Everywhere
SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Gainsight, a world-leading Customer Success platform, today acquired Skilljar, a leading Learning Management Software (LMS) provider for external training, marking a pivotal shift in how businesses approach …

Global Helium Corp. Announces Sale of Standing Well and Lands in Montana
CALGARY, Alberta, April 02, 2025 (GLOBE NEWSWIRE) -- Global Helium Corp. ("HECO" or the "Company") (CSE: HECO, OTC: HECOF) is pleased to announce the successful sale of one standing well and one section of associated mineral rights located in the Rudyard …

Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025
During the first 16 weeks of the Extension phase of the RewinD-LB clinical study neflamapimod slowed clinical progression compared to controls, as assessed by Clinical Dementia Rating Sum of Boxes (CDR-SB) and Clinical Global Impression of Change (CGIC) …

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference
CHATHAM, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth Lederman M.D., …

Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases
The undisclosed target is a central regulator of inflammation that is distinct from the previously disclosed STAT6 program Nurix DEL-AI drug discovery engine generated a drug discovery program to this previously undruggable target Nurix received a $15 …